SCHEMBL5000663

SCHEMBL5000663

Cc1ccc(Cc2ccccc2[O])cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
STAT3 P40763 1/20 0.40
HTT P42858 1/20 0.40
KCNH2 Q12809 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KEAP1 Q14145 1/20 0.39
SRD5A2 P31213 1/20 0.39
SLC5A2 P31639 2/20 0.38
HSP90AA1 P07900 1/20 0.38
TSHR P16473 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9403954 0.84 SLC6A2 (0.47) POLBLMNAALOX12TDP1KEAP1
SCHEMBL780045 0.82 CALM1 (0.52) SMN1; SMN2HPGDTSHRCYP3A4CYP2D6
SCHEMBL6547993 0.81 POLB (0.45) POLBSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL6378299 0.80 POLB (0.51) POLBMEN1KMT2AKEAP1SLC5A2
SCHEMBL2140027 0.80 HTR2A (0.54) POLBSMN1; SMN2LMNAALOX12HTT
SCHEMBL5004420 0.79 LTA4H (0.60) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
SCHEMBL28534678 0.78 SLC6A4 (0.47) POLBLMNATDP1KEAP1
SCHEMBL2186450 0.77 HSPA5 (0.46) MEN1KMT2AMAPTNPSR1TDP1
SCHEMBL6546906 0.76 CNR2 (0.39) POLBSMN1; SMN2KEAP1SLC5A2TSHR
SCHEMBL10727696 0.76 ALDH1A1 (0.52) POLBSMN1; SMN2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414063-B2 Inhibitors of Akt (protein kinase B) ELI LILLY AND COMPANY (US) 2008-08-19 US disclosed
US-20070043040-A1 Inhibitors of akt (protein kinase b) ELI LILLY AND COMPANY 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043040-A1 Inhibitors of akt (protein kinase b) AKT1, AKT2, BRAF POLB 525/4885SMN1; SMN2 2866/4885MEN1 1215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.